DRUG/AGENT TOXICITY BY TISSUE/ORGAN

Clinical trials for DRUG/AGENT TOXICITY BY TISSUE/ORGAN explained in plain language.

Never miss a new study

Get alerted when new DRUG/AGENT TOXICITY BY TISSUE/ORGAN trials appear

Sign up with your email to follow new studies for DRUG/AGENT TOXICITY BY TISSUE/ORGAN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Major trial tests safer drug for Kids' leukemia

Disease control Completed

This study aimed to find the best way to give a crucial drug called asparaginase to children with acute lymphoblastic leukemia (ALL). It directly compared a newer, longer-lasting version given by IV with the standard version given by injection. The main goal was to see which meth…

Matched conditions: DRUG/AGENT TOXICITY BY TISSUE/ORGAN

Phase: PHASE3 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

DRUG/AGENT TOXICITY BY TISSUE/ORGAN

Get alerted when new DRUG/AGENT TOXICITY BY TISSUE/ORGAN trials appear

Major trial tests safer drug for Kids' leukemia